Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea in Sickle Cell Anemia
NCT00001197Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Feb 1984
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxyurea in sickle cell anemia (SCA), sponsored by National Heart, Lung, and Blood Institute. Started Feb 1984; status: completed.
02
Drugs
hydroxyurea
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT00001197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001197.